Pluri (PLUR) Debt to Equity (2018 - 2025)

Pluri (PLUR) reported Debt to Equity of -$3.02 for Q4 2025, up 63.04% year-over-year from -$1.85 in Q4 2024, and up 38.17% quarter-over-quarter from -$4.88 in Q3 2025.

Pluri (PLUR) Debt to Equity (2018 - 2025) Analysis & Trends

Pluri (PLUR) has 6 years of Debt to Equity data on file, last reported at -$3.02 in Q4 2025.

  • Debt to Equity for Q4 2025 came in at -$3.02, up 63.04% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.02 (up 63.04% YoY), and the FY2025 annual result was -$3.99, down 189.89% from the prior year.
  • Debt to Equity improved to -$3.02 in Q4 2025 per PLUR's latest filing, from -$4.88 in the prior quarter.
  • Over five years, Debt to Equity peaked at $13.04 in Q1 2024 and troughed at -$402.62 in Q3 2024.
  • A 5-year average of -$20.94 and a median of $0.58 in 2021 frame the typical range for Debt to Equity.
  • On a YoY basis, Debt to Equity climbed as much as 1066.62% in 2024 and fell as far as 19278.79% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.58 in 2021, then soared by 56.25% to $0.91 in 2022, then jumped by 306.02% to $3.69 in 2023, then plunged by 321.24% to -$8.16 in 2024, then jumped by 63.04% to -$3.02 in 2025.
  • Business Quant data shows PLUR's Debt to Equity at -$3.02 in Q4 2025, -$4.88 in Q3 2025, and -$3.99 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 -3.02

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.02
Sep 30, 2025 -4.88
Jun 30, 2025 -3.99
Mar 31, 2025 -5.58
Dec 31, 2024 -8.16
Sep 30, 2024 -402.62
Jun 30, 2024 4.44
Mar 31, 2024 13.04
Dec 31, 2023 3.69
Sep 30, 2023 2.10
Jun 30, 2023 1.54
Mar 31, 2023 1.12
Dec 31, 2022 0.91
Sep 30, 2022 0.77
Jun 30, 2022 0.67
Mar 31, 2022 0.57
Dec 31, 2021 0.58
Sep 30, 2021 0.48
Jun 30, 2021 0.42
Jun 30, 2018 0.01